Advertisement
Advertisement
BMEA
Biomea Fusion, Inc. Common Stock
0.56
USDSponsored
-0.05
-7.89%
Nov 12, 16:00 UTC -5
Closed
Pre-Market
0.59
+0.02
+4.14%
Biomea Fusion, Inc. Common Stock (BMEA) Earnings
BMEA Earnings Reports
Positive Surprise Ratio
BMEA beat 11 of 23 last estimates.
48%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Biomea Fusion, Inc. Common Stock earnings per share and revenue
On Nov 10, 2026, BMEA reported earnings of -0.09 USD per share (EPS) for Q3 26, beating the estimate of -0.21 USD, resulting in a 57.69% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +11.68% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Yarrow Bioscience, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.43
Surprise
+40.62%
Pelthos Therapeutics Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$2.20
Actual
-$3.09
Surprise
-39.99%
Bolt Biotherapeutics, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$3.75
Actual
-$2.25
Surprise
+40.14%
Ascendis Pharma A/S Ordinary Share
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.95
Actual
$1.08
Surprise
+12.85%
Arrowhead Research Corporation
Report Date
Nov 12, 2026 For Q4 26
Estimate
-$1.61
Actual
-$3.04
Surprise
-87.84%
Generate Biomedicines, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.56
Actual
-$0.68
Surprise
-19.76%
MeiraGTx Holdings plc Ordinary Shares
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.53
Surprise
-4.76%
Alumis Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.76
Actual
-$0.73
Surprise
+4.19%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.09
Actual
$0.12
Surprise
+26.72%
Lineage Cell Therapeutics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.02
Actual
-$0.03
Surprise
-3.09%
FAQ
What were Biomea Fusion, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Biomea Fusion, Inc. Common Stock reported EPS of -$0.09, beating estimates by 57.69%, and revenue of $0.00, 0% as expectations.
How did the market react to Biomea Fusion, Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 11.68%, changed from $0.55 before the earnings release to $0.61 the day after.
When is Biomea Fusion, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Biomea Fusion, Inc. Common Stock's next earnings report?
Based on --
analysts, Biomea Fusion, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.